特别提示：包括重组SARS-CoV-2 N-NTD(His标签)在内，本公司的所有产品仅可用于科研实验，严禁用于临床医疗及其他非科研用途！

产品名称：重组SARS-CoV-2 N-NTD(His标签)
英文名称：Recombinant SARS-CoV-2 NP NTD domain(N-His)
产品货号：JN2090
产品规格：1mg

本制品由E.coli表达系统制备，目的基因编码表达SARS-CoV-2 Nucleocapsid蛋白NTD域，N端带有一个6*his标签，用作免疫原或标准品。

技术指标：
Accession#：QHD43423.2
分子量：15.9kDa
实测分子量：16kDa（还原条件下）
纯度：＞95%（还原性SDS-PAGE）
纯化方式：亲和色谱法
贮存液：PBS,2M Urea,pH7.4，0.2μm过滤
保存条件：-20℃。

背景资料：
Coronavirus N protein is required for coronavirus RNA synthesis,and has RNA chaperone activity that may be involved in template switch.Nucleocapsid protein is a most abundant protein of coronavirus.N protein packages the positive strand viral genome RNA into a helical ribonucleocapsid (RNP) and plays a fundamental role during virion assembly through its interactions with the viral genome and membrane protein M.Plays an important role in enhancing the efficiency of subgenomic viral RNA transcription as well as viral replication.Because of the conservation of N protein sequence and its strong immunogenicity,the N protein of coronavirus is chosen as a diagnostic tool.

根据您的关注的重组SARS-CoV-2 N-NTD(His标签)(＞95%)，重组新型冠状病毒NP蛋白NTD域，Recombinant SARS-CoV-2 NP NTD domain(N-His)，重组SARS-CoV-2 NP-NTD，重组SARS-CoV-2 N-NTD，重组新冠病毒NP蛋白NTD域，重组His标签，重组SARS-CoV-2 NP NTD domain(N-His)，重组新冠病毒N蛋白NTD域，重组新冠病毒核衣壳蛋白NTD域，您可能还对以下产品有需求：

 

货号	名称	规格
JN0444	重组人骨保护素(TNFRSF11B)	10μg|50μg|500μg|1mg
JN2025	重组人铜耐受蛋白A(CutA蛋白)	10μg|50μg|500μg|1mg
JN0570	重组人壳三糖酶1(CHIT1)	10μg|50μg|500μg|1mg
JN0641	重组人促肾上腺皮质激素释放因子结合蛋白(CRHBP)(CRFBP)	10μg|50μg|500μg|1mg
JN0711	重组人N-乙酰-D-氨基葡糖激酶(NAGK)	10μg|50μg|500μg|1mg
JN0740	重组人Protocadherin-1(PCDH1)(原钙粘蛋白1)	10μg|50μg|500μg|1mg

关注重组SARS-CoV-2 N-NTD(His标签)(＞95%)，重组新型冠状病毒NP蛋白NTD域，Recombinant SARS-CoV-2 NP NTD domain(N-His)，重组SARS-CoV-2 NP-NTD，重组SARS-CoV-2 N-NTD，重组新冠病毒NP蛋白NTD域，重组His标签，重组SARS-CoV-2 NP NTD domain(N-His)，重组新冠病毒N蛋白NTD域，重组新冠病毒核衣壳蛋白NTD域的同时，为您推荐更多您可能感兴趣的产品：



名称：重组人VEGF-A(血管内皮生长因子A)(带His标签)
货号：JN0245
规格：10μg|50μg|500μg|1mg
本品由我们的哺乳动物表达系统制备，目的基因编码的Ala27-Arg147在C端含有His标签。

VEGF121质量控制：＞95%(还原性SDS-PAGE)。

VEGF121制剂：冻干品

VEGF121保存：
冻干蛋白可在-20℃长期保存，室温也可稳定保存3周。
复溶蛋白溶液可在4～7℃保存2～7天。
复溶后建议分装冻存在-20℃，可保存3个月，应避免反复冻融。

VEGF121复溶：
1、试剂开盖前请先离心。
2、复溶浓度应大于100 μg/ml.
3、冻干蛋白溶于ddH2O中
4、复溶后根据使用量分装保存，避免反复冻融。

关于VEGF121：
Human VEGF121, also known as Vascular endothelial growth factor A, VEGFA, Vascular permeability factor, VPF and VEGF, is a homodimeric, heparin-binding glycoprotein which belongs to the platelet-derived growth factor (PDGF)/vascular endothelial growth factor (VEGF) family. VEGF-A is a glycosylated mitogen that specifically acts on endothelial cells and has various effects, including mediating increased vascular permeability, inducing angiogenesis, vasculogenesis, permeabilization of blood vessels and endothelial cell growth, increasing microvascular permeability, promoting cell migration and inhibiting apoptosis. Alternatively spliced transcript variants of VEGF-A encod either secreted or cell-associated isoforms. The lymphangiogenesis may be promoted by upregulation of VEGF121, which may in turn act in part via induction of VEGF-C. It binds to the FLT1/VEGFR1 and KDR/VEGFR2 receptors, heparan sulfate and heparin. NRP1/Neuropilin-1 binds isoforms VEGF-165 and VEGF-145. Isoform VEGF165B binds to KDR but does not activate downstream signaling pathways, does not activate angiogenesis and inhibits tumor growth.